TI
GBT

Telemetry Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Telemetry Investments’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,200
Closed -$218K – 213
2022
Q3 		$218K Buy
+3,200
New +$176K 0.28% 91

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Telemetry Investments's GBT Position: Q4 2022 in Review

Telemetry Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,200 shares — an estimated $218K sold.

Telemetry Investments first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $218K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Telemetry Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Telemetry Investments sold 3,200 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $218K.
  • Telemetry Investments first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Telemetry Investments's Global Blood Therapeutics, Inc. position peaked at $218K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.